Back

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Time and space in acute coronary syndrome Infarction acute phase STEMI ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Mikkel Schoos

Zealand University Hospital, Roskilde (Denmark)

23 More presentations in this session

Presentation thumbnail
System delay time effect on ventricular dysfunction and in-hospital mortality after primary angioplasty: Influence of infarct location.
Doctor F. Rivero (Madrid, ES)
Abstract
Presentation thumbnail
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: the ATLANTIC ST-segment resolution substudy
Associate Professor E. Fabris (Trieste, IT)
Abstract Slides
Presentation thumbnail
Reduction of ischemic time for transferred ST-elevation myocardial infarction patients using a smartphone social network system: 1-year experience
Associate Professor J. Park (Seongnam, KR)
Abstract Slides
Presentation thumbnail
The additive impact of reduced symptom-to-door Time and door-to-balloon time on long-term survival rates in acute STEMI patients undergoing primary percutaneous coronary intervention
Doctor K. Chang (Taichung, TW)
Abstract
Presentation thumbnail
Effect of immediate invasive strategy on the 4-year clinical outcomes in patients with non-ST segment elevation myocardial infarction: long-term results of the RIDDLE-NSTEMI randomized trial
Doctor A. Milosevic (Belgrade, RS)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Time and space in acute coronary syndrome

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources